课题基金 / 基金详情

A PHASE II DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE

A PHASE II DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE
一项 II 期双盲、随机、安慰剂对照研究来评估
批准号：
7717987
负责人：
RONALD T. MITSUYASU
金额：
$0.35万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-12-01 至 2008-11-30
来源：
https://reporter.nih.gov/project-details/7717987
关键词：
Computer Retrieval of Information on Scientific Projects DatabaseDouble-Blind MethodFundingGrantInstitutionInterruptionPhasePlacebosResearchResearch PersonnelResourcesSourceUnited States National Institutes of HealthVaccinesViralWeekrandomized placebo controlled trial

项目摘要

项目成果

RONALD T. MITSUYASU的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Primary Objective: To determine if the MRK Ad5 vaccine has an effect of maintaining viral suppression following interruption of ART over 16 weeks post-ART interruption, versus placebo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
South American Prevention of HIV Research Training Program (SAPHIR)
South American Prevention of HIV Research Training Program (SAPHIR)